China National Chemical Corporation (ChemChina) — Ethics Grade F

China National Chemical Corporation (ChemChina) receives an overall ethics grade of F (12/100) on CancelCo's corporate accountability database. Sector: Pharmaceuticals. Market cap: Large Cap.

Category scores

• labor: 25
• privacy: 40
• consumer: 10
• environment: 15
• humanRights: 20

Documented incidents (3)

• Paraquat Health Risks (high, 2021) — The company faced thousands of lawsuits alleging that exposure to the herbicide Paraquat causes Parkinson's disease. Internal documents suggested the company was aware of health risks for decades while maintaining it was safe.
• Global Seed Market Concentration (medium, 2017) — The $43 billion acquisition of Syngenta sparked major antitrust concerns regarding the concentration of the global seed and pesticide markets. Regulators forced divestitures to prevent excessive price control over farmers.
• Jiangsu Explosion Compliance (high, 2019) — Following massive chemical plant explosions in China, the company faced scrutiny over safety protocols and environmental compliance at various manufacturing sites. This led to nationwide government crackdowns on chemical giants.

Documented good deeds

• Investment in Sustainable Seeds — Invested $500 million into developing drought-resistant crop varieties to help farmers adapt to climate change.

Ethical alternatives

• Corteva Agriscience — Better transparent reporting on chemical safety and stronger ESG commitments in US and EU markets.